Pharmacological studies on 5-(3-(4-piperidino-4-carbamoyl-piperidino)-propyl)-10,11-dihydro-5(H)-dibenz-(b,f)-azepine (carpipramine) dihydrochloride, a new psychotropic agent.
D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000633:toxicity; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology* / Q000633:toxicity; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001552:Benzazepines / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D003214:Conditioning, Classical / Q000187:drug effects; D003864:Depression, Chemical; D004285:Dogs; D004357:Drug Synergism; D004597:Electroshock; D005260:Female; D006168:Guinea Pigs; D007099:Imipramine / Q000494:pharmacology*; D066298:In Vitro Techniques; D008124:Locomotion / Q000187:drug effects; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D010880:Piperidines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D012890:Sleep / Q000187:drug effects; D013268:Stimulation, Chemical; D013997:Time Factors; D014203:Tremorine / Q000037:antagonists & inhibitors
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents; D001552:Benzazepines; D010880:Piperidines; D012110:Reserpine; D000661:Amphetamine; D001058:Apomorphine; D007099:Imipramine; D014203:Tremorine